Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Free PDFs: Hepatology 2013 (574 pages) – Hepatitis C 2013 Amedeo Smart: the Smartphone Edition	Free Abstracts

Malignant Melanoma

Free Subscription Articles published in Cancer Retrieve available abstracts of 37 articles: HTML format Text format

Single Articles

May 2013
1. HAMILTON R , Krauze M, Romkes M, Omolo B, et al
   Pathologic and gene expression features of metastatic melanomas to the brain.
   Cancer. 2013 May 21. doi: 10.1002/cncr.28029.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2013
2. PRINTZ C
   New research on melanoma risk in red-haired people.
   Cancer. 2013;119:1118.
   PubMed     Text format     Related articles   
   
   
   
   
3. GAMBA CA , Swetter SM, Stefanick ML, Kubo J, et al
   Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative.
   Cancer. 2013 Mar 11. doi: 10.1002/cncr.27817.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2013
4. BAGARIA SP , Ray PS, Joseph RW, Heckman MG, et al
   Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma.
   Cancer. 2013 Feb 13. doi: 10.1002/cncr.27985.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. WEBER JS , Dummer R, de Pril V, Lebbe C, et al
   Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: Detailed safety analysis from a phase 3 trial in patients with advanced melanoma.
   Cancer. 2013 Feb 7. doi: 10.1002/cncr.27969.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2012
6. BEASLEY GM , Sharma K, Wong J, Miller M, et al
   A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion.
   Cancer. 2012;118:6136-43.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. PRINTZ C
   Strides in personalized medicine.
   Cancer. 2012;118:5722-3.
   PubMed     Text format     Related articles   
   
   
   
   September 2012
8. PATEL SP , Lazar AJ, Papadopoulos NE, Liu P, et al
   Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma.
   Cancer. 2012 Sep 12. doi: 10.1002/cncr.27790.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. PRINTZ C
   Genetic test predicts whether eye cancer will spread.
   Cancer. 2012;118:4096.
   PubMed     Text format     Related articles   
   
   
   
   August 2012
10. KOTTSCHADE LA , Suman VJ, Perez DG, McWilliams RR, et al
    A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group study, N0775.
    Cancer. 2012 Aug 22. doi: 10.1002/cncr.27760.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. KIM KB
    Is there a role for targeting vascular endothelial growth factor/receptor axis in the treatment of patients with metastatic melanoma?
    Cancer. 2012 Aug 22. doi: 10.1002/cncr.27756.
    PubMed     Text format     Related articles   
    
    
    
    June 2012
12. MURALI R , Brown PT, Kefford RF, Scolyer RA, et al
    Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma.
    Cancer. 2012 Jun 26. doi: 10.1002/cncr.27693.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. PRINTZ C
    Declines in melanoma deaths occur in most-educated individuals.
    Cancer. 2012;118:3001.
    PubMed     Text format     Related articles   
    
    
    
    May 2012
14. JOHANNESDOTTIR SA , Chang ET, Mehnert F, Schmidt M, et al
    Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: A population-based case-control study.
    Cancer. 2012 May 29. doi: 10.1002/cncr.27406.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. CURIEL-LEWANDROWSKI C , Swetter SM, Einspahr JG, Hsu CH, et al
    Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: Evaluation of potential chemopreventive activity.
    Cancer. 2012 May 17. doi: 10.1002/cncr.27540.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. MU E , Lange JR, Strouse JJ
    Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma.
    Cancer. 2012;118:2700-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2012
17. KATALINIC A , Waldmann A, Weinstock MA, Geller AC, et al
    Does skin cancer screening save lives?: An observational study comparing trends in melanoma mortality in regions with and without screening.
    Cancer. 2012 Apr 19. doi: 10.1002/cncr.27566.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2012
18. JAGTAP D , Rosenberg CA, Martin LW, Pettinger M, et al
    Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative.
    Cancer. 2012 Mar 20. doi: 10.1002/cncr.27497.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
19. HWA C , Price LS, Belitskaya-Levy I, Ma MW, et al
    Single versus multiple primary melanomas: Old questions and new answers.
    Cancer. 2012 Jan 13. doi: 10.1002/cncr.27407.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
20. JAKOB JA , Bassett RL Jr, Ng CS, Curry JL, et al
    NRAS mutation status is an independent prognostic factor in metastatic melanoma.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26724.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. SWETTER SM , Pollitt RA, Johnson TM, Brooks DR, et al
    Behavioral determinants of successful early melanoma detection: Role of self and physician skin examination.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26707.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. POLLITT RA , Swetter SM, Johnson TM, Patil P, et al
    Examining the pathways linking lower socioeconomic status and advanced melanoma.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26706.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
23. PRINTZ C
    Duke University researchers develop laser-based tool for melanoma.
    Cancer. 2011;117:4338-9.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
24. JENSEN TO , Schmidt H, Moller HJ, Donskov F, et al
    Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
    Cancer. 2011 Sep 22. doi: 10.1002/cncr.26511.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
25. ERMAN AB , Collar RM, Griffith KA, Lowe L, et al
    Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
    Cancer. 2011 Jul 19. doi: 10.1002/cncr.26288.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
26. ZHANG Z , Chen G, Cheng Y, Martinka M, et al
    Prognostic significance of RUNX3 expression in human melanoma.
    Cancer. 2011;117:2719-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
27. KLUGER HM , Dudek AZ, McCann C, Ritacco J, et al
    A phase 2 trial of dasatinib in advanced melanoma.
    Cancer. 2011;117:2202-8.
    PubMed     Text format     Related articles   
    
    
    
    
28. GADIOT J , Hooijkaas AI, Kaiser AD, van Tinteren H, et al
    Overall survival and PD-L1 expression in metastasized malignant melanoma.
    Cancer. 2011;117:2192-201.
    PubMed     Text format     Related articles   
    
    
    
    
29. MCLAUGHLIN JM , Fisher JL, Paskett ED
    Marital status and stage at diagnosis of cutaneous melanoma: Results from the Surveillance Epidemiology and End Results (SEER) program, 1973-2006.
    Cancer. 2011;117:1984-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
30. ZAKRZEWSKI J , Geraghty LN, Rose AE, Christos PJ, et al
    Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival.
    Cancer. 2011;117:1711-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. KOTTSCHADE LA , Suman VJ, Amatruda T 3rd, McWilliams RR, et al
    A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group Study, N057E(1).
    Cancer. 2011;117:1704-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. EIGENTLER TK , Figl A, Krex D, Mohr P, et al
    Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma.
    Cancer. 2011;117:1697-1703.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. OTHUS M , Moon J, Margolin K
    Melanoma's deadly march to the brain: By what route, and can it be stopped?
    Cancer. 2011;117:1560-3.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
34. KIRKWOOD JM , Gonzalez R, Reintgen D, Clingan PR, et al
    A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26068.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. SOSMAN JA , Moon J, Tuthill RJ, Warneke JA, et al
    A phase 2 trial of complete resection for stage IV melanoma: Results of Southwest Oncology Group Clinical Trial S9430.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26111.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. OLLILA DW
    A phase 2 trial of complete resection for stage IV melanoma : Results of Southwest Oncology Group Clinical Trial S9430.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26118.
    PubMed     Text format     Related articles   
    
    
    
    
37. KELLY P , Zagars GK, Cormier JN, Ross MI, et al
    Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: A 20-Year Experience.
    Cancer. 2011 Mar 28. doi: 10.1002/cncr.26088.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through a media sponsorship by Boehringer Ingelheim.

All AMEDEO services are free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Amedeo is a Flying Publisher website.    Design: